Cas:58888-84-9 3-Hydroxy Valproic Acid manufacturer & supplier

We serve Chemical Name:3-Hydroxy Valproic Acid CAS:58888-84-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-Hydroxy Valproic Acid

Chemical Name:3-Hydroxy Valproic Acid
CAS.NO:58888-84-9
Synonyms:3-hydroxy-2-propylpentanoic acid
Molecular Formula:C8H16O3
Molecular Weight:160.21100
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:280.7ºC at 760 mmHg
Density:1.043g/cm3
Index of Refraction:1.461
PSA:57.53000
Exact Mass:160.11000
LogP:1.25820

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like 3-hydroxy-2-propylpentanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-hydroxy-2-propylpentanoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-hydroxy-2-propylpentanoic acid Use and application,3-hydroxy-2-propylpentanoic acid technical grade,usp/ep/jp grade.


Related News: But even though weight-loss success depends on adopting a challenging” change in post-operation diet and lifestyle, the process can certainly “help people to lose weight and get comorbid [other negative health] conditions under better control,” Sandon said.
So it’s important, she said, to help eligible patients better “understand the treatment options and potential for success,” by sharing surgery success stories and highlighting the benefits of reducing high-risk health issues such as blood pressure and diabetes.
An experimental Alzheimer’s vaccine appears to safely clear abnormal tau protein from the brain, but it’s not yet clear whether the shot will be able to save brain function.
In a Phase 2 clinical trial, the vaccine produced high levels of antibodies to target and attack free-floating tau proteins before they can form “tau tangles” that clog neurons and damage brain function. Tau tangles, along with plaques formed by the protein amyloid-beta, serve as one of the main hallmarks of Alzheimer’s.
“While amyloid influences speed of Alzheimer’s progression, there is strong evidence that tau pathology relates to the underlying cause of the disease,” said lead researcher Dr. Petr Novak, a senior clinical research scientist at AXON Neuroscience, the Slovakian pharmaceutical company developing the vaccine. “Brain atrophy and cognitive loss closely echo the deposition of pathological tau protein, as evidenced by recent tau PET studies. 3-Hydroxy Valproic Acid manufacturer The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. 3-Hydroxy Valproic Acid supplier The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. 3-Hydroxy Valproic Acid vendor The second is known as the excipient, which is the inactive substance that serves as the vehicle for the API itself. 3-Hydroxy Valproic Acid factory The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes.